News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Antitope and Vascular Pharmaceuticals Enter into a Antibody Research Agreement


6/30/2009 11:48:57 AM

CAMBRIDGE, UK - 29th June, 2008 - Antitope, a privately held biotechnology company, today announced a research agreement with Vascular Pharmaceuticals, Inc. for the generation of therapeutic antibodies for treatment of vascular disease. The agreement brings together Vascular Pharmaceuticals' expertise in therapeutic antibody discovery and Antitope's Composite Human AntibodyTM technology for engineering of fully-humanized antibodies.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES